Frontotemporal lobar degeneration (FTLD) is an umbrella term for a heterogeneous group of young-onset dementias of uncertain prevalence and incidence worldwide. Atypical cases of FTLD with fused in sarcoma inclusions (aFTLD-U) have been described recently, but their molecular characterization is still due. Using shotgun mass spectrometry, we identified a total of 107 differentially expressed proteins in the prefrontal cortex, cerebellum and occipital lobe from aFTLD-U patients compared to controls. These proteins are involved in a range of biological pathways such as cellular transport in the prefrontal cortex, energy metabolism in the cerebellum, and protein metabolism in the occipital lobe. In addition, they were validated by selective re...
Frontotemporal dementia is characterized by progressive atrophy of frontal and/or temporal cortices ...
In the last decade, there has been enormous progress in our understanding of Frontotemporal Lobar De...
Introduction: Reliable cerebrospinal fluid (CSF) biomarkers enabling identification of frontotempora...
Frontotemporal lobar degeneration (FTLD) is a neurodegenerative disorder clinically characterized by...
Frontotemporal lobar degeneration (FTLD) is a neurodegenerative disorder clinically characterized by...
Frontotemporal lobar degeneration (FTLD) is the most common cause of dementia with pre-senile onset,...
Semantic dementia (SD) is a clinical subtype of frontotemporal dementia consistent with the neuropat...
Frontotemporal dementia is a group of early onset dementia syndromes linked to underlying frontotemp...
Background: frontotemporal lobar degeneration with TDP-43 immunoreactive inclusions (FTLD-TDP) may a...
A hallmark of neurodegeneration is the aggregation of disease related proteins that are resistant to...
Frontotemporal dementia (FTD) is a clinical syndrome with a heterogeneous molecular basis. Familial ...
Frontotemporal dementia (FTD) is a clinical syndrome with a heterogeneous molecular basis. The neuro...
(1) Background: Amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD) are neurodegen...
Frontotemporal dementia is characterized by progressive atrophy of frontal and/or temporal cortices ...
In the last decade, there has been enormous progress in our understanding of Frontotemporal Lobar De...
Introduction: Reliable cerebrospinal fluid (CSF) biomarkers enabling identification of frontotempora...
Frontotemporal lobar degeneration (FTLD) is a neurodegenerative disorder clinically characterized by...
Frontotemporal lobar degeneration (FTLD) is a neurodegenerative disorder clinically characterized by...
Frontotemporal lobar degeneration (FTLD) is the most common cause of dementia with pre-senile onset,...
Semantic dementia (SD) is a clinical subtype of frontotemporal dementia consistent with the neuropat...
Frontotemporal dementia is a group of early onset dementia syndromes linked to underlying frontotemp...
Background: frontotemporal lobar degeneration with TDP-43 immunoreactive inclusions (FTLD-TDP) may a...
A hallmark of neurodegeneration is the aggregation of disease related proteins that are resistant to...
Frontotemporal dementia (FTD) is a clinical syndrome with a heterogeneous molecular basis. Familial ...
Frontotemporal dementia (FTD) is a clinical syndrome with a heterogeneous molecular basis. The neuro...
(1) Background: Amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD) are neurodegen...
Frontotemporal dementia is characterized by progressive atrophy of frontal and/or temporal cortices ...
In the last decade, there has been enormous progress in our understanding of Frontotemporal Lobar De...
Introduction: Reliable cerebrospinal fluid (CSF) biomarkers enabling identification of frontotempora...